Concepedia

Zhi-di Li

ZL

Statistics

Publications

2

Citations

33

H-Index

2

Active since

2022

Affiliations

Zhejiang University(Current)

Taizhou University

Zhi-di Li is an author at Zhejiang University specializing in molecular oncology, pharmacology, and oncology.

Publications per year

2022–2022

2

Publications

2

DYRK1A suppression attenuates HIF‑1α accumulation and enhances the anti‑liver cancer effects of regorafenib and sorafenib under hypoxic conditions

Chong Zhang, Lin‐wen Wu, Zhi-di Li et al. · International Journal of Oncology · 2022 · 17 citations · Full text

, , +17

Harmine reinforces the effects of regorafenib on suppressing cell proliferation and inducing apoptosis in liver cancer cells

Ziyi Chen, Jie Li, Shu-Di Zhu et al. · Experimental and Therapeutic Medicine · 2022 · 16 citations · Full text

, , +16

1–2 of 2